Compound optimization,
accelerated.

Leverage data from thousands of programs and advanced Machine Learning (ML) models to solve challenging small molecule ADMET issues.

Built by industry veterans
Inductive Bio brings the data, ML, software, and expertise needed to rapidly solve your most challenging ADMET problems.
DATA

Proprietary ADMET Data

We have the most comprehensive and best-curated commercially available dataset to map the drivers of small-molecule ADMET. Inductive's proprietary training sets are carefully normalized to account for the heterogeneity in real-world data and are continuously growing to fill in gaps for specific chemotypes and assays.

Models

Built for Purpose ML

We've built high-performing models that can be used confidently for decision making in real drug programs. We started with the state-of-the-art in deep learning and then built custom architectures on top that are adapted to the unique needs of real-world heterogeneous ADMET data.

Software

Intuitive Design Platform

Our easy-to-use chemistry design software makes ML accessible to your whole team with little ramp-up time. It provides real-time predictions as compounds are drawn, providing a data-driven input and acting as an experienced collaborator in the design process.

Team

Interdisciplinary Expertise

Our team has deep experience both building innovative machine learning products and bringing drugs into the clinic. We know what it takes to translate the state of the art in machine learning into real-world impact on complex drug programs.

Arrow
Meet the Inductive team

Working with Inductive

Software Partnerships

Put advanced ML models, trained on thousands of programs-worth of data, at the fingertips of every scientist on your team to guide design cycles towards the most promising compounds.

Scientific Collaborations

Tackle your hardest ADMET challenges by integrating world-class ML, medicinal chemistry, synthetic chemistry, and DMPK expertise directly into your design-make-test-analyze cycle.

Investors

Backed by some of the best investors at the intersection of tech and bio.

Investors of Inductive Bio, including a16z, Lux, Bessemer, Alley Corp, Character, and Amino Collective